Efficacy of a fourth dose of Covid-19 mRNA vaccine against Omicron
A Fourth Dose of mRNA Vaccine in Health Care Workers Health care workers in Israel were
given a fourth dose of BNT162b2 or mRNA-1273 vaccine during a period of omicron-variant …
given a fourth dose of BNT162b2 or mRNA-1273 vaccine during a period of omicron-variant …
[HTML][HTML] Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
G Regev-Yochay, T Gonen, M Gilboa… - The New England … - ncbi.nlm.nih.gov
To the Editor: In this open-label, nonrandomized clinical study, we assessed the
immunogenicity and safety of a fourth dose of either BNT162b2 (Pfizer–BioNTech) or mRNA …
immunogenicity and safety of a fourth dose of either BNT162b2 (Pfizer–BioNTech) or mRNA …
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
G Regev-Yochay, T Gonen, M Gilboa… - The New England …, 2022 - pubmed.ncbi.nlm.nih.gov
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron Efficacy of a Fourth
Dose of Covid-19 mRNA Vaccine against Omicron N Engl J Med. 2022 Apr 7;386(14):1377-1380 …
Dose of Covid-19 mRNA Vaccine against Omicron N Engl J Med. 2022 Apr 7;386(14):1377-1380 …
[引用][C] Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
G Regev-Yochay, T Gonen, M Gilboa… - New England Journal …, 2022 - cris.bgu.ac.il
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron — Ben-Gurion
University Research Portal Skip to main navigation Skip to search Skip to main content Ben-Gurion …
University Research Portal Skip to main navigation Skip to search Skip to main content Ben-Gurion …
[引用][C] Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
G Regev-Yochay, T Gonen, M Gilboa… - New England Journal …, 2022 - cir.nii.ac.jp
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[引用][C] Efficacy of a fourth dose of COVID-19 mRNA vaccine against omicron.
G Regev-Yochay, T Gonen, M Gilboa, M Mandelboim… - 2022 - cabidigitallibrary.org
Skip the header click to show the menu Menu Cart Login Login/Register Institutional Access
Access Options Enter words / phrases / DOI / ISBN / keywords / authors / etc Search Advanced …
Access Options Enter words / phrases / DOI / ISBN / keywords / authors / etc Search Advanced …
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.
G Regev-Yochay, T Gonen, M Gilboa… - The New England …, 2022 - europepmc.org
To the Editor: In this open-label, nonrandomized clinical study, we assessed the
immunogenicity and safety of a fourth dose of either BNT162b2 (Pfizer–BioNTech) or mRNA …
immunogenicity and safety of a fourth dose of either BNT162b2 (Pfizer–BioNTech) or mRNA …
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
G Regev-Yochay, T Gonen, M Gilboa… - The New England …, 2022 - pubmed.ncbi.nlm.nih.gov
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron Efficacy of a Fourth
Dose of Covid-19 mRNA Vaccine against Omicron N Engl J Med. 2022 Apr 7;386(14):1377-1380 …
Dose of Covid-19 mRNA Vaccine against Omicron N Engl J Med. 2022 Apr 7;386(14):1377-1380 …
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.
G Regev-Yochay, T Gonen, M Gilboa… - The New England …, 2022 - europepmc.org
To the Editor: In this open-label, nonrandomized clinical study, we assessed the
immunogenicity and safety of a fourth dose of either BNT162b2 (Pfizer–BioNTech) or mRNA …
immunogenicity and safety of a fourth dose of either BNT162b2 (Pfizer–BioNTech) or mRNA …